Aspira Pathlab & Diagnostics Limited (BSE: 540788)
Health Care · Health Care Providers & Services · IN
Rs90.05
-9.50% today · +46.4% 1Y
Aspira Pathlab & Diagnostics Limited (BSE: 540788) operates in the Health Care Providers & Services industry within the Health Care sector. The company is valued at $9.69M.
Over the last twelve months the share price has gained 46.4%, trading between 49.00 and 135.88.
Tweenvest scores Aspira Pathlab & Diagnostics Limited across four factors: quality 62/100, value 46/100, growth 40/100. Its strongest factor is quality.
540788 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $9.69M
- Revenue (TTM)
- $2.74M
- P/E
- —
- EPS
- -0.41
- Dividend yield
- —
- Beta (5Y)
- 0.46
- 52-week high
- Rs135.88
- 52-week low
- Rs49.00
- Avg volume (3M)
- —
- Shares outstanding
- 10.29M
- Employees
- —
- Next earnings
- —
Other Health Care Providers & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| UnitedHealth Group IncorporatedNYSE: UNH | $355.98B | $401.01 | +1.11% |
| CVS Health CorporationNYSE: CVS | $118.82B | $94.32 | +1.53% |
| McKesson CorporationNYSE: MCK | $105.52B | $896.65 | -0.93% |
| HCA Healthcare, Inc.NYSE: HCA | $92.83B | $427.16 | -0.37% |
| Elevance Health, Inc.NYSE: ELV | $86.50B | $402.54 | +0.92% |
| The Cigna GroupNYSE: CI | $73.81B | $280.87 | +0.55% |
| Cencora, Inc.NYSE: COR | $62.60B | $327.79 | -0.08% |
| Cardinal Health, Inc.NYSE: CAH | $55.33B | $238.40 | +0.20% |
Figures last refreshed Aug 18, 2026.